The heterogeneity of Human Papilloma Virus genotypes in the oropharyngeal cavity, anus, and urogenital sites.

The distribution of Human Papilloma Virus (HPV) genotypes is not homogeneous among the infectedcells in a specific anatomical site. Thus, we conducted a prospective cross-sectional studywith 2,130 Mexican men and women aged 16 to 80 years. We described the prevalence of HPVgenotypes at the oropharyngeal cavity, anus, and urogenital sites. The most prevalent genotypes inwomen were HR-HPV 66 (5.6%), 16 (4.2%), 59 (4.3%) and LR-HPV 6 (10.1%); for men, HR-HPV16 (4.2%), 53 (3.8%), 66 (3.5%) and LR-HPV 6 (14.1%). In the cervix the most frequent genotypeswere: 6 (7.7%) and 66 (4.6%); vagina 6 (0.4%) and 16 (0.4%); genital wart 6 (5.9%) and 11 (2.7%);external genitalia 6 (0.5%) and 66 (0.5%); oropharyngeal cavity 6 (0.06%) and 66 (0.05%). In bothgenders, the most frequent genotype was HPV 6. The prevalence of HPV genotypes 31 (p=0.016),52 (p=0.049), 56 (0.036), 6 (p<0.0001) and 11 (p<0.0001) showed significant differences when comparinggenders. The kappa analysis demonstrated that in males, the HPV genotypes in the urethra/balanopreputial sulcus and urethral/genital warts had moderate concordance. In conclusion, HPVgenotyping screening tests among anatomical sites should be performed simultaneously to reinforcecurrent strategies, as well as for the development of vaccines and the discovery of oncogenic potentialfor genotypes that are not commonly analyzed.